¥36.43 ($5.43)

+0.74 (+2.07%)

SHZ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 38 · ¥13.0B mcap · 295M float · 2.56% daily turnover

Revenue

$1.9B +32.4% ▲

5Y CAGR: +29.1%

Gross Profit

$1.5B +34.7% ▲

5Y CAGR: +30.9%

Operating Income

$425M +53.6% ▲

5Y CAGR: +62.3%

Net Income

$338M +40.8% ▲

5Y CAGR: +56.6%

EPS (Diluted)

$1.38 -28.5% ▼

5Y CAGR: +34.0%

EBITDA

$500M +46.9% ▲

5Y CAGR: +45.0%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$689M	$1.0B	$1.2B	$1.5B	$1.9B
YoY Growth	+27.0%	+49.3%	+21.6%	+17.4%	+32.4%
Cost of Revenue	$188M	$229M	$270M	$340M	$425M
Gross Profit	$501M	$799M	$980M	$1.1B	$1.5B
Gross Margin	72.7%	77.7%	78.4%	76.8%	78.2%
R&D Expenses	$63M	$88M	$146M	$167M	$226M
SG&A Expenses	$320M	$457M	$595M	$690M	$876M
Operating Expenses	$395M	$551M	$730M	$851M	$1.1B
Operating Income	$106M	$248M	$250M	$277M	$425M
Operating Margin	15.4%	24.2%	20.0%	18.8%	21.9%
Interest Expense	$6M	$7M	$2M	$2M	$7M
Income Before Tax	$103M	$244M	$234M	$265M	$395M
Tax Expense	$9M	$34M	$22M	$25M	$57M
Net Income	$88M	$195M	$212M	$240M	$338M
Net Margin	12.8%	18.9%	16.9%	16.4%	17.4%
EPS (Diluted)	$1.08	$2.27	$1.71	$1.93	$1.38
EBITDA	$158M	$298M	$297M	$340M	$500M
Shares Outstanding	82M	86M	124M	124M	175M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$547M	$504M	$536M	$627M	$741M	$569M	$683M	$718M
Cost of Revenue	$115M	$113M	$106M	$126M	$131M	$110M	$123M	$138M
Gross Profit	$433M	$391M	$430M	$501M	$610M	$459M	$561M	$580M
Gross Margin	79.1%	77.5%	80.2%	79.9%	82.4%	80.6%	82.1%	80.8%
R&D Expenses	$61M	$87M	$47M	$45M	$63M	$71M	$84M	$70M
SG&A Expenses	$227M	$239M	$205M	$239M	$234M	-$215M	$241M	$248M
Operating Expenses	$289M	$318M	$252M	$283M	$308M	$340M	$328M	$329M
Operating Income	$144M	$72M	$178M	$218M	$302M	$119M	$233M	$251M
Operating Margin	26.2%	14.4%	33.2%	34.7%	40.8%	20.9%	34.0%	35.0%
Interest Expense	$2M	$2M	$2M	$1M	$1M	$631K	$481K	$196K
Income Before Tax	$138M	$57M	$178M	$207M	$304M	$112M	$230M	$252M
Tax Expense	$16M	$10M	$32M	$18M	$40M	$15M	$24M	$28M
Net Income	$121M	$47M	$146M	$189M	$264M	$97M	$206M	$224M
Net Margin	22.2%	9.4%	27.2%	30.2%	35.6%	17.0%	30.2%	31.2%
EPS (Diluted)	$0.70	$0.27	$0.83	$0.77	$1.08	$0.39	$0.84	$0.63
EBITDA	$161M	$92M	$208M	$222M	$305M	$143M	$231M	$285M
Shares Outstanding	174M	178M	176M	245M	245M	251M	246M	357M

300573.SZ SHZ